Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NSE - Delayed Quote INR

Tatva Chintan Pharma Chem Limited (TATVA.NS)

Compare
653.55
-30.85
(-4.51%)
At close: 3:30:03 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
3,701,070
3,904,950
4,208,910
4,312,930
2,968,570
Cost of Revenue
1,920,230
1,834,710
2,345,910
2,076,780
1,583,580
Gross Profit
1,780,840
2,070,240
1,863,000
2,236,150
1,384,990
Operating Expense
1,619,290
1,629,030
1,275,650
1,228,100
784,640
Operating Income
161,550
441,210
587,350
1,008,050
600,350
Net Non Operating Interest Income Expense
19,690
-34,460
-32,660
-5,650
-40,880
Pretax Income
192,430
435,680
447,790
1,041,210
606,960
Tax Provision
49,460
132,140
-7,080
82,470
84,340
Net Income Common Stockholders
142,970
303,540
454,870
958,740
522,620
Diluted NI Available to Com Stockholders
142,970
303,540
454,870
958,740
522,620
Basic EPS
6.13
13.26
20.52
44.59
23.58
Diluted EPS
6.13
13.26
20.52
44.59
23.58
Basic Average Shares
23,413.20
22,889.19
22,165.06
21,499.10
22,165.06
Diluted Average Shares
23,413.20
22,889.19
22,165.06
21,499.10
22,165.06
Rent Expense Supplemental
--
15,440
18,780
11,400
14,480
Total Expenses
3,539,520
3,463,740
3,621,560
3,304,880
2,368,220
Net Income from Continuing & Discontinued Operation
142,970
303,540
454,870
958,740
522,620
Normalized Income
143,705.54
304,227.46
481,246
959,596.34
523,102.22
Interest Income
--
32,840
53,340
46,680
3,590
Interest Expense
7,360
61,510
79,970
43,510
39,850
Net Interest Income
19,690
-34,460
-32,660
-5,650
-40,880
EBIT
199,790
497,190
527,760
1,084,720
646,810
EBITDA
466,130
753,240
623,310
1,166,520
714,140
Reconciled Cost of Revenue
1,920,230
1,834,710
2,345,910
2,076,780
1,583,580
Reconciled Depreciation
266,340
256,050
95,550
81,800
67,330
Net Income from Continuing Operation Net Minority Interest
142,970
303,540
454,870
958,740
522,620
Total Unusual Items Excluding Goodwill
-990
-990
-37,680
-930
-560
Total Unusual Items
-990
-990
-37,680
-930
-560
Normalized EBITDA
467,120
754,230
660,990
1,167,450
714,700
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-254.46
-302.54
-11,304
-73.66
-77.78
3/31/2021 - 7/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ASAHISONG.NS Asahi Songwon Colors Limited
348.05
-1.43%
 
SHK.NS S H Kelkar and Company Limited
170.85
-1.87%
 
BODALCHEM.NS Bodal Chemicals Limited
60.45
-3.71%
 
KIRIINDUS.NS Kiri Industries Limited
566.60
-5.20%
 
CAMLINFINE.NS Camlin Fine Sciences Limited
137.29
-8.81%
 
STALLION.BO Stallion India Fluorochemicals Limited
67.66
-9.74%
 
LXCHEM.NS Laxmi Organic Industries Limited
166.96
-3.14%
 
FCL.NS Fineotex Chemical Limited
217.00
-5.57%
 
GALAXYSURF.NS Galaxy Surfactants Limited
2,137.30
-0.79%
 
LXCHEM.BO Laxmi Organic Industries Limited
166.50
-3.53%